Risk factors for new thromboembolic stroke in patients ≥62 years of age with chronic atrial fibrillation
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
In a prospective study of 312 older patients with chronic atrial fibrillation, at 36-month follow-up evaluation, new thromboembolic stroke developed in 162 of 312 patients (52%). Significant independent risk factors for new thromboembolic stroke were prior stroke (risk ratio = 1.6), rheumatic mitral stenosis (risk ratio = 2.0), left ventricular (LV) hypertrophy (risk ratio = 2.8), abnormal LV ejection fraction (risk ratio = 1.8), serum total cholesterol (risk ratio = 1.005), and serum high-density lipoprotein cholesterol (risk ratio = 0.96).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Diabetes is probably not the most potent independent risk factor for stroke in AF compared with the other items in the CHA 2 DS 2 -VASc score, but it is included in this risk-stratification tool, giving a point alongside most other items.600,618,[622][623][624]”
From 2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes. (2023) · cites this paper as [622]
Citations
Cites
Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
(1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420130036007 · Cited by 2,071
EAFT (European Atrial Fibrillation Trial) Study Group (1993) · The Lancet · doi:10.1016/0140-6736(93)92358-z · Cited by 1,741
(1990) · New England Journal of Medicine · doi:10.1056/nejm199011293232201 · Cited by 1,530
Echocardiographic measurements in normal subjects from infancy to old age.
Henry, W. L., Gardin, J. M., & Ware, J. H. (1980) · Circulation · doi:10.1161/01.cir.62.5.1054 · Cited by 631
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
Predictors of Thromboembolism in Atrial Fibrillation: I. Clinical Features of Patients at Risk
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-1 · Cited by 477
Devereux, R. B., Casale, P. N., Kligfield, P., Eisenberg, R. R., Miller, D., Campo, E., & Alonso, D. R. (1986) · The American Journal of Cardiology · doi:10.1016/0002-9149(86)90224-9 · Cited by 190
Master, A. M. (1960) · Journal of the American Medical Association · doi:10.1001/jama.1960.03020070016005 · Cited by 153
Aronow, W. S., Ahn, C. W., & Kronzon, I. (1990) · The American Journal of Cardiology · doi:10.1016/0002-9149(90)91112-j · Cited by 146
Self-citation
Research works printed but not linked: 1
- Peterson, 1990, Risk factors for thromboembolic complications in chronic atrial fibrillation, Arch Intern Med, 150, 819, 10.1001/archinte.1990.00390160077016 · doi:10.1001/archinte.1990.00390160077016
Cited by
2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes.
Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R. A., Antunes, M. J., Christodorescu, R. M., Crawford, C., Di Angelantonio, E., Eliasson, B., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad192 · Cited by 1,642
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Hughes, M., Lip, G. Y. H., & on behalf of the Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care (2008) · Thrombosis and Haemostasis · doi:10.1160/th07-08-0508 · Cited by 371
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis
Ko, D., Rahman, F., Schnabel, R. B., Yin, X., Benjamin, E. J., & Christophersen, I. E. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.45 · Cited by 353
Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention
Hart, R. G., & Halperin, J. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00010 · Cited by 269
Metadata
- Authors
- Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H.
- Affiliations
- Hebrew Hospital (US)
- The University of Texas Health Science Center at Houston (US)
- New York University (US)
- Corresponding author
- Aronow, Wilbert S.
- ORCID
- Ahn, Chul
- Venue
- The American Journal of Cardiology
- Publisher
- Elsevier BV
- Published
- 1998-07
- Volume
- 82
- Issue
- 1
- Pages
- 119-A9
- ISSN
- 0002-9149 (ISSN-L)
- OpenAlex
- W2109828699
- Cited by
- 74
- References
- 16
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 4 · 2017: 3 · 2016: 1 · 2015: 7 · 2014: 4 · 2013: 3 · 2012: 8
- FWCI
- 3.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The American Journal of Cardiology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Internal Medicine › Venous Thromboembolism Diagnosis and Management
- Keywords
- thromboembolic stroke, chronic atrial fibrillation, stroke risk factors, elderly patients, anticoagulation, warfarin, oral anticoagulation, left atrial enlargement, diabetes mellitus, paroxysmal supraventricular tachycardia, atrial fibrillation, stroke prevention, antithrombotic therapy, risk stratification
- MeSH terms
- Adult, Aged, Aged, 80 and over, Atrial Fibrillation, Intracranial Embolism and Thrombosis, Female, Humans, Male, Middle Aged, Prospective Studies, Risk Factors, Odds Ratio
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Risk factors for new thromboembolic stroke in patients ≥62 years of age with chronic atrial fibrillation. https://app.cochat.ai/papers/10.1016/s0002-9149(98)00247-1
- The paper
- Aronow, W. S., Ahn, C., Kronzon, I., & Gutstein, H. (1998). Risk factors for new thromboembolic stroke in patients ≥62 years of age with chronic atrial fibrillation. The American Journal of Cardiology. https://doi.org/10.1016/s0002-9149(98)00247-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.